Financial Performance - The company's revenue for Q1 2025 was CNY 245,188,828.52, representing a 19.65% increase compared to CNY 204,929,240.40 in the same period last year[3]. - Net profit attributable to shareholders was CNY 108,236,874.48, up 24.08% from CNY 87,228,395.78 year-over-year[3]. - Basic and diluted earnings per share increased by 27.78% to CNY 0.23 from CNY 0.18 in the previous year[4]. - Total operating revenue for Q1 2025 reached ¥245,188,828.52, an increase of 19.5% compared to ¥204,929,240.40 in Q1 2024[19]. - Net profit for Q1 2025 was ¥107,786,272.75, representing a 23.5% increase from ¥87,075,680.66 in Q1 2024[20]. - The company's total comprehensive income for Q1 2025 was ¥123,142,728.35, compared to ¥90,397,978.13 in Q1 2024, an increase of 36.3%[21]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 4,639,554,478.66, a 3.20% increase from CNY 4,495,821,916.06 at the end of the previous year[4]. - The company's current assets reached CNY 2,581,193,766.69, up from CNY 2,473,078,015.08, indicating an increase of about 4.4%[15]. - The company's total liabilities increased to ¥574,464,302.84 in Q1 2025, compared to ¥552,798,705.10 in Q1 2024, reflecting a growth of 3.1%[17]. - The total equity attributable to shareholders rose to ¥4,063,487,267.59 in Q1 2025, up from ¥3,940,969,701.00 in Q1 2024, marking an increase of 3.1%[17]. Cash Flow - The cash flow generated from operating activities was CNY 140,037,835.33, reflecting a 5.22% increase from CNY 133,086,579.74 in the same period last year[4]. - The cash inflow from operating activities for Q1 2025 showed a positive trend, indicating improved liquidity and operational efficiency[22]. - In Q1 2025, the cash inflow from operating activities was $315,702,694.25, an increase of 14.2% compared to $276,340,855.26 in Q1 2024[23]. - The net cash flow from operating activities for Q1 2025 was $140,037,835.33, up from $133,086,579.74 in Q1 2024, reflecting a growth of 5.4%[24]. - The cash outflow from financing activities in Q1 2025 was $1,105,814.69, compared to $177,480,673.80 in Q1 2024, showing a reduction of 99.4%[24]. Research and Development - Research and development expenses totaled CNY 21,330,798.19, accounting for 8.70% of revenue, down from 9.68% in the previous year[4]. - The company has committed to ongoing research and development to enhance its product offerings and market position[4]. - The company invested a total of 12,186,716.38 yuan in the research of the swine pseudorabies gene engineering live vaccine, achieving new veterinary drug registration[11]. - The company has established a cooperation research and development management system with Huazhong Agricultural University, ensuring competitive negotiation for future projects[10]. - The company is actively engaged in the research and development of various vaccines and diagnostic kits, with multiple products in different stages of clinical trials and registrations[12][13]. Shareholder Information - The largest shareholder, Wuhan Huazhong Agricultural University, holds 16.73% of the shares[9]. - The second-largest shareholder, Chen Huan Chun, holds 15.20% of the shares[9]. - The total number of ordinary shareholders at the end of the reporting period was 7,968[8]. - The company has not reported any changes in the participation of major shareholders in margin trading and securities lending[10].

招商证券股份有限公司 关于武汉科前生物股份有限公司 2024 年度募集资金存放与实际使用情况的专项核查意见 招商证券股份有限公司（以下简称"招商证券"或"保荐机构"）作为武汉 科前生物股份有限公司（以下简称"科前生物"或"公司"）首次公开发行股票 的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券交易所股票科 创板上市规则》《上市公司监管指引第 2 号——上市公司募集资金管理和使用的 监管要求》以及《上海证券交易所科创板上市公司自律监管指引第 1 号——规范 运作》等有关规定，对科前生物 2024 年度募集资金存放与实际使用情况进行了 审慎核查，核查意见如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到位时间 根据中国证券监督管理委员会出具的《关于同意武汉科前生物股份有限公司 首次公开发行股票注册的批复》（证监许可(2020)1909 号），并经上海证券交易 所同意，公司由主承销商招商证券采用向战略投资者定向配售、网下向符合条件 的投资者询价配售和网上向持有上海市场非限售 A 股股份和非限售存托凭证市 值的社会公众投资者定价发行相结合的方式，发行了普通股（A 股）股票 10,500.00 万 ...

华兴会计师事务所(特殊普通合伙) 武汉科前生物股份有限公司 2024 年度募集资金存放与实际使用情况的 专项鉴证报告 华兴专字[2025]24014440030 号 您可使用手机"扫一扫"或进入"注册会计师行业统一些管理会 兴会计师事务所(特殊普通合伙 ING CERTIFIED PUBLIC ACCOUNTANT Rlock R. 152 Hudong Road Fuzhou Fujian China 申话(Tel):0591-87852 武汉科前生物股份有限公司 2024年度募集资金存放与实际使用情况的 专项鉴证报告 华兴专字[2025]24014440030号 武汉科前生物股份有限公司全体股东: 我们接受委托,对后附的武汉科前生物股份有限公司(以下简称"科前生 物")董事会编制的《2024年度募集资金存放与实际使用情况的专项报告》(以 下简称"专项报告")执行了合理保证的鉴证业务。 一、董事会的责任 头会计师事务所(特殊普通台 C CERTIFIED PUBLIC ACCOUNT 按照《上市公司监管指引第 2 号 -- 上市公司募集资金管理和使用的监 管要求》和《上海证券交易所科创板上市公司自律监管指引 ...

Investment Rating - The report maintains a "Recommended" investment rating for the industry, suggesting a potential upside of over 15% relative to benchmark indices [4]. Core Insights - The swine industry shows stable breeding profits, with a focus on capacity reduction logic. The average price of external three yuan pigs was 15.0 CNY/kg, up 2.1% week-on-week, while the average weight of pigs sold was 128.6 kg, down 0.2% [19][20]. - The beef industry is at an inflection point, with strong price performance continuing. The average price of calves was 28.2 CNY/kg, up 2.1%, and the average price of fattened cattle was 25.8 CNY/kg, up 0.7% [23][30]. - The white chicken market is affected by ongoing avian influenza, with significant impacts on breeding stock and prices. The average price of white feather broiler chicks was 2.8 CNY/chick, up 9.5% [31][34]. - The animal health sector is seeing a recovery in demand as breeding supply stabilizes, with a notable increase in the issuance of vaccines [48][49]. Summary by Sections Swine Industry - The average price of external three yuan pigs was 15.0 CNY/kg, reflecting a week-on-week increase of 2.1%. The average weight of pigs sold was 128.6 kg, down 0.2%. The price of 15 kg external three yuan piglets was 668 CNY/head, with a slight decrease of 0.05% [19][21]. - Supply pressure remains stable, with normal sales rhythms from large producers and limited sales from smallholders. The demand side shows increased activity from secondary breeding, but overall consumption remains weak [20][21]. - The report recommends companies such as Muyuan Foods, Wens Foodstuff Group, and New Hope Liuhe for investment [20]. Beef Industry - The beef breeding industry is entering a capacity release phase, with the earliest signs of a price bottom forming. The report anticipates a potential recovery in the industry by late 2025 or early 2026 [23][30]. - The average wholesale price of beef was 61.4 CNY/kg, reflecting a slight increase of 0.2% [29][30]. - Recommended companies include Fucheng Co. and Guangming Meat Industry, focusing on integrated breeding and sales [23]. Poultry Industry - The average price of white feather broiler eggs was 1.6 CNY/egg, up 2.0%, while the average price of white feather broilers was 3.7 CNY/kg, up 2.2% [31][34]. - The report highlights the impact of avian influenza on breeding imports, particularly from the U.S. and New Zealand, which has been suspended for over three months [31][32]. - Recommended companies include Yisheng Livestock and He Feng Food [31]. Animal Health Sector - The demand for animal health products is expected to recover as breeding supply stabilizes. The issuance of vaccines has shown significant increases, particularly for swine diseases [48][49]. - The report recommends companies like Kexin Biological and Zhongmu Biotechnology, which are positioned to benefit from the recovery in the animal health market [49].

今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 供销社 | 3.93 | 中国AI 50 | -2.09 | | 跨境支付(CIPS) | 3.65 | 人形机器人 | -1.59 | | 草甘膦 | 3.57 | 英伟达概念 | -1.48 | | 中韩自贸区 | 3.16 | 同花顺果指数 | -1.38 | | 自由贸易港 | 3.05 | 算力租赁 | -1.32 | | 统一大市场 | 2.74 | 液冷服务器 | -1.28 | | 数字货币 | 2.63 | 华为手机 | -1.22 | | 转基因 | 2.62 | AI手机 | -1.21 | | 信托概念 | 2.33 | MLOps概念 | -1.21 | | 电子身份证 | 2.04 | 太赫兹 | -1.21 | 资金面上看，今日转基因概念板块获主力资金净流入0.60亿元，其中，7股获主力资金净流入，5股主力 资金净流入超千万元，净流入资金居首的是神农种业，今日主力资金净流入8224.06万元，净流入资金 居前的还有大北农、敦煌种业、 ...

Investment Rating - The report maintains a "Recommended" rating for the agriculture, forestry, animal husbandry, and fishery industry [1] Core Views - The report highlights the weak fluctuation of pig prices, with expectations of a downward trend in the short term and a long-term weak operation in 2025 due to increased supply and weak demand [4][14] - The poultry sector may see price improvements due to the impact of tariffs and a shortage of quality breeding stock caused by avian influenza [5][28] - The animal health sector is expected to benefit from improved downstream demand and external expansion opportunities, with rising prices for key products like Tylosin [6][41] - The planting sector is experiencing price fluctuations for major grains, with a focus on the commercialization of genetically modified seeds [8][46] - The feed sector is seeing a decline in prices, with recommendations for companies like Haida Group [8][49] - The pet market continues to grow rapidly, with strong performance from domestic brands and recommendations for companies in the pet food and medical sectors [8][54][57] Summary by Sections Pig Industry - Pig prices are expected to adjust slightly, with a forecast of weak performance in 2025 due to increased supply [4][14] - As of April 10, 2025, the average price of live pigs is 14.6 CNY/kg, with no change from the previous week [14] Poultry Industry - The poultry sector may see price increases due to tariff impacts and a lack of quality breeding stock [5][28] - The average price of broiler chickens is 3.75 CNY/lb, reflecting a weekly increase [28] Animal Health - The animal health sector is experiencing improved profitability, with Tylosin prices rising significantly [6][41] - The report suggests focusing on companies with expected external expansion, such as Reap Bio [6] Planting Sector - Major grain prices are fluctuating, with corn priced at 2199 CNY/ton and wheat at 2422 CNY/ton [8][46] - The report recommends companies involved in genetically modified seed development [8] Feed Sector - Feed prices are declining, with pig feed at 3.35 CNY/kg [8][49] - The report suggests focusing on companies like Haida Group due to expected industry consolidation [8] Pet Industry - The pet market is projected to reach 300.2 billion CNY in 2024, with a growth rate of 7.5% [8][54] - Recommendations include companies like Guobao Pet and Zhongchong Co., which are experiencing significant growth [8][57]

证券代码：688526 证券简称：科前生物 武汉科前生物股份有限公司 2025 年员工持股计划 二〇二五年四月 武汉科前生物股份有限公司 2025 年员工持股计划 声明 本公司及全体董事、监事保证本员工持股计划及其摘要不存在虚假记载、误 导性陈述或重大遗漏，并对其真实性、准确性、完整性承担个别和连带的法律责 任。 本员工持股计划所有持有人承诺，若公司因信息披露文件中有虚假记载、误 导性陈述或者重大遗漏，导致不符合解锁安排的，持有人应当自相关信息披露文 件被确认存在虚假记载、误导性陈述或者重大遗漏后，将由本员工持股计划所获 得的全部利益返还公司。 1 武汉科前生物股份有限公司 2025 年员工持股计划 风险提示 一、有关本员工持股计划的具体资金来源、出资比例、实施方案等属初步结 果，能否完成实施，存在不确定性。 二、若员工认购资金较低，则本员工持股计划存在不能成立的风险；若员工 认购资金不足，本员工持股计划存在低于预计规模的风险。 三、公司后续将根据规定披露相关进展情况，敬请广大投资者谨慎决策，注 意投资风险。 2 武汉科前生物股份有限公司 2025 年员工持股计划 特别提示 一、武汉科前生物股份有限公司（以下 ...

证券代码：688526 证券简称：科前生物 公告编号：2025-013 武汉科前生物股份有限公司 2025 年第一次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 4 月 11 日 （二） 股东大会召开的地点：湖北武汉东湖新技术开发区高新二路 419 号科前 生物二楼会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 60 | | --- | --- | | 普通股股东人数 | 60 | | 2、出席会议的股东所持有的表决权数量 | 233,746,317 | | 普通股股东所持有表决权数量 | 233,746,317 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 50.3854 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 50.3 ...

科前生物 2025年第一次临时股东大会 法律意见书 磊源律师事务所 IA YUAN LAW OFFICES 北京 BEIJING·上海 SHANGHAI·深圳 SHENZHEN·香港 HONGKONG·广州 GUANGZHOU·西安 XI'AN 致:武汉科前生物股份有限公司 北京市嘉源律师事务所 北京市嘉源律师事务所 关于武汉科前生物股份有限公司 2025 年第一次临时股东大会的 法律意见书 西城区复兴门内大街 158 号远洋大厦 4 楼 中国·北京 二〇二五年四月 2. 公司于 2025 年 3 月 25 日在《中国证券报》《上海证券报》《证券时报》 《证券日报》及上海证券交易所网站（www.sse.com.cn）上发出《武汉科前生物 股份有限公司关于召开 2025 年第一次临时股东大会的通知》 ( 以下简称"会议通 知"）。该会议通知载明了会议召开的时间、地点、会议审议事项、股东大会投 科前生物 2025 年第一次临时股东大会 法律意见书 关于武汉科前生物股份有限公司 2025 年第一次临时股东大会的 法律意见书 嘉源(2025)-04-192 受武汉科前生物股份有限公司(以下简称"科前生物"或"公司") ...

截至4月11日收盘，转基因概念下跌5.96%，位居概念板块跌幅榜前列，板块内，万向德农跌停，神农 种业、敦煌种业、丰乐种业等跌幅居前，股价上涨的有3只，涨幅居前的有芭田股份、金城医药、科前 生物等，分别上涨5.63%、1.91%、1.07%。 转基因概念资金流出榜 | 代码 | 简称 | 今日涨跌幅（%） | 今日换手率（%） | 主力资金流量（万元） | | --- | --- | --- | --- | --- | | 002385 | 大北农 | -7.17 | 10.09 | -15703.93 | | 300087 | 荃银高科 | -8.83 | 12.71 | -10991.72 | | 300189 | 神农种业 | -13.04 | 40.95 | -10713.62 | | 000998 | 隆平高科 | -5.46 | 7.89 | -6747.25 | | 002041 | 登海种业 | -6.88 | 6.53 | -5055.55 | | 000713 | 丰乐种业 | -9.02 | 18.03 | -4946.29 | | 600354 | 敦煌种业 | -9.25 | 20. ...